FNDC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 4.620400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
3.199200E-01
Normal-vs-Stage2
4.762600E-01
Normal-vs-Stage3
3.611400E-01
Normal-vs-Stage4
5.114600E-01
Stage1-vs-Stage2
7.078400E-03
Stage1-vs-Stage3
5.161200E-01
Stage1-vs-Stage4
1.938200E-02
Stage2-vs-Stage3
3.332400E-01
Stage2-vs-Stage4
8.319400E-01
Stage3-vs-Stage4
1.347230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
4.613600E-01
Normal-vs-AfricanAmerican
4.706200E-01
Normal-vs-Asian
4.946000E-01
Caucasian-vs-AfricanAmerican
9.666400E-01
Caucasian-vs-Asian
7.482600E-01
AfricanAmerican-vs-Asian
8.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
4.514800E-01
Normal-vs-Female
4.775000E-01
Male-vs-Female
5.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
3.614000E-01
Normal-vs-Age(41-60Yrs)
4.815800E-01
Normal-vs-Age(61-80Yrs)
4.665600E-01
Normal-vs-Age(81-100Yrs)
3.790200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.544600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.433200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.960600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.249800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.382500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.087600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
4.400200E-01
Normal-vs-Daily Drinker
4.198200E-01
Normal-vs-Weekly Drinker
5.839400E-01
Normal-vs-Occasional Drinker
4.097800E-01
Normal-vs-Social Drinker
4.515000E-01
Non Drinker-vs-Daily Drinker
7.402800E-01
Non Drinker-vs-Weekly Drinker
1.428160E-01
Non Drinker-vs-Occasional Drinker
6.249000E-01
Non Drinker-vs-Social Drinker
9.203800E-01
Daily Drinker-vs-Weekly Drinker
7.798100E-02
Daily Drinker-vs-Occasional Drinker
8.541800E-01
Daily Drinker-vs-Social Drinker
7.101000E-01
Weekly Drinker-vs-Occasional Drinker
8.225900E-02
Weekly Drinker-vs-Social Drinker
2.760800E-01
Occasional Drinker-vs-Social Drinker
6.288000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
6.780800E-01
Normal-vs-Grade 2
7.855600E-01
Normal-vs-Grade 3
7.308000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.712400E-02
Grade 1-vs-Grade 3
3.327200E-01
Grade 1-vs-Grade 4
6.780800E-01
Grade 2-vs-Grade 3
2.629200E-01
Grade 2-vs-Grade 4
7.855600E-01
Grade 3-vs-Grade 4
7.308000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
4.910200E-01
Normal-vs-NonDiabetic
4.683600E-01
Diabetic-vs-NonDiabetic
6.971000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
4.617000E-01
Normal-vs-NoPancreatitis
4.593000E-01
Pancreatitis-vs-NoPancreatitis
9.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
4.626400E-01
Normal-vs-N1
4.699400E-01
N0-vs-N1
8.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
3.547800E-01
Normal-vs-TP53-NonMutant
2.715200E-01
TP53-Mutant-vs-TP53-NonMutant
7.711800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap